Trends in Cardiometabolic Testing: Lipoprotein(a) and Natriuretic Peptide Testing
Alex Fohl, PharmD
Fully automated platforms and diagnostics partnerships are essential for clinical labs to manage increasing cardiometabolic test volumes
Alex Fohl, PharmD
Alex Fohl has been at Roche Diagnostics since 2017, focusing on the cardiac portfolio and is the scientific partner for cardiometabolism. Prior to joining Roche, Fohl was a clinical pharmacist at Indiana University Health in Indiana and Community Hospital where he precepted students and residents. Fohl is a licensed pharmacist who earned his Doctor of Pharmacy degree from Purdue University and completed a two-year pharmacy practice residency in Critical Care from the University of Michigan Hospitals and Health Centers.